Christoph Harms
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms 13
- Developmental Neuroscience top 2%
-
- Neuroscience and Neuropharmacology Research 11
- Genetic Neurodegenerative Diseases 7
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 8
- Ion channel regulation and function 5
- Mitochondrial Function and Pathology 5
- Cell death mechanisms and regulation 5
- Genetics top 5%
- Glioma Diagnosis and Treatment 5
- Co-authors
- Matthias EndresUlrich DirnaglKaren GertzHeide HörtnaglJuri KatchanovGolo KronenbergKlaus FinkAndreas Meisel
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Christoph Harms
79 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 129
- Neurology 505
- Developmental Neuroscience 249
- Cellular and Molecular Neuroscience 516
- Molecular Biology 1.6k
- Genetics 189
Countries citing papers authored by Christoph Harms
This map shows the geographic impact of Christoph Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Harms more than expected).
Fields of papers citing papers by Christoph Harms
This network shows the impact of papers produced by Christoph Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Harms. The network helps show where Christoph Harms may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christoph Harms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 8 | |
| 13 | 2017 | 25 | |
| 14 | 2017 | 8 | |
| 15 | 2016 | 9 | |
| 16 | 2012 | 53 | |
| 17 | 2008 | 85 | |
| 18 | 2007 | 25 | |
| 19 | 2006 | 9 | |
| 20 | 2000 | 50 |
About Christoph Harms
Christoph Harms is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics, having authored 80 papers that have together received 3.3k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (13 papers), Neuroscience and Neuropharmacology Research (11 papers), Ubiquitin and proteasome pathways (8 papers), Genetic Neurodegenerative Diseases (7 papers), Glioma Diagnosis and Treatment (5 papers), Ion channel regulation and function (5 papers), Mitochondrial Function and Pathology (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Neurology (505 citations), Developmental Neuroscience (249 citations) and Cellular and Molecular Neuroscience (516 citations). Christoph Harms has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Matthias Endres, Ulrich Dirnagl, Karen Gertz, Heide Hörtnagl, Juri Katchanov, Golo Kronenberg, Klaus Fink, Andreas Meisel, Ulrike Harms and Ludger Hauck. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.